Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Each year, 40 percent of all injury-related emergency room visits and 42 percent of all injury-related deaths happen between May and August.* Additionally, one in four children ages 14 and younger will sustain an injury that requires medical attention. The good news is that most of these injuries are preventable with education and simple precautions.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7141051-shriners-hospital-for-children-nascar-david-ragan-summer-safety
In celebration of National Reading Month, CITGO Petroleum Corporation, along with its mobile literacy partner, Bess the Book Bus, is kicking off its second annual literacy campaign to share the excitement of reading with thousands of children in more than 100 schools and Children’s Hospitals across the United States. From Feb. 26 to March 9, CITGO representatives, Miss America 2017-2018 State Titleholders and Bess the Book Bus will deliver brand new, free books to schools in 19 states, while special read-alouds for children will focus on the joy and importance of reading every day.
Founded in 2002 by Jennifer Frances, whose grandmother Bess O'Keefe fueled a love of reading from a young age, Bess the Book Bus aims to bring that same love of reading to children everywhere. Since inception, and with support from sponsors like CITGO, Bess the Book Bus travels nationwide and has visited 48 states, reaching more than 300,000 children in underserved communities and donating more than 650,000 books.
To view the multimedia release go to:
https://www.multivu.com/players/English/8281251-citgo-literacy-campaign-national-reading-month-fueling-good/
The science of bionics helped the more than 1 million Americans with leg amputations take a giant step forward, as the Rehabilitation Institute of Chicago (RIC) revealed clinical applications for the world’s first thought-controlled bionic leg in this week’s New England Journal of Medicine. This innovative technology represents a significant milestone in the rapidly-growing field of bionics. Until now, only thought-controlled bionic arms were available to amputees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63339-rehabilitation-institute-of-chicago-first-thought-controlled-bionic-leg
What if there were a way to prevent a leading cause of childhood death, but three out of four of us were doing it wrong? The startling truth is that a car seat can dramatically reduce childhood death and injury from motor vehicle crashes, but 75 percent are installed incorrectly.1
With Child Passenger Safety Week upon us, the good news is that community-based programs are making a difference. Buckle Up for Life is a national education program, created in 2004 by Cincinnati Children's Hospital Medical Center and Toyota, to save children's lives. Over the last ten years, it has grown to include a network of more than a dozen of the nation's leading children's hospitals and has educated more than 17,000 people about the proper use of car seats and seat belts. Toyota's sponsorship has provided funding for over 40,000 car seats for families in need.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7318951-toyota-cincinnati-children-s-hospital-child-passenger-safety-buckle-up-for-life/
Cardinal Health, which provides medical products and services to many of America’s most prestigious medical institutions, today announced the launch of the Hospital Quality at Home™ brand, a new line of hospital-quality products available over the counter to help loved ones and caregivers transition care from the hospital to home. The product line provides a full assortment of hospital-quality products for consumers categorized as Advanced Wound Care, First Aid, Personal Care, and Home Healthcare which help provide comfort and independence, while helping to promote healing.
When leaving the hospital after childbirth, injury or surgery, the care you provide for yourself or a loved one is important. Each year, hospitals discharge 35.1 million patients1 with 65 percent of those discharged to the home setting for care.2 Effective post-hospital care is critical to avoid re-admission as one in five patients are readmitted within 30 days of discharge.2 With rising health care costs3 the Hospital Quality at Home™ line of products can provide patients, loved ones, and caregivers effective and cost-efficient ways to manage care at home.
To view the multimedia release go to:
http://www.multivu.com/players/English/7622451-cardinal-health-hospital-quality-at-home/
The full set of data from EUCLID, the largest ever prevalence study of Clostridium difficile infection (CDI) across Europe, were presented today at the 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Data from 482 European hospitals reveal that in a single day, an average of 109 cases of CDI are missed due to a lack of clinical suspicion or inadequate laboratory testing, potentially leading to more than 39,000 missed cases in Europe each year.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400524-EUCLID-clostridium-difficile-infection
Cancer Treatment Centers of America® (CTCA), a national network of comprehensive cancer care hospitals and outpatient care centers, and Foundation Medicine, a leading molecular insights company that recently received FDA approval for its FoundationOne CDx™ genomic test, today announced the launch of a collaborative educational campaign designed to heighten awareness of the promise of precision medicine and the role that advanced genomic testing plays in helping identify treatments best suited for individual patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8295651-cancer-treatment-centers-of-america-foundation-medicine-precision-cancer-treatment/
As millions of Americans begin choosing a health plan for the first time under the Affordable Care Act, the new Healthgrades American Hospital Quality Outcomes 2014: Report to the Nation released today reveals how hospital selection can dramatically impact a patient’s health. The report demonstrates that individuals are far more likely to die or suffer complications at hospitals receiving the lowest Healthgrades rating. In fact, each year an estimated 234,252 lives could potentially be saved and 157,418 complications could be avoided if all hospitals performed similarly to the highest rated hospitals.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63942-healthgrades-american-hospital-quality-outcomes-2014-report-to-the-nation
EXTNGO, 50 Feet CAT 6 Flat Retractable Network Ethernet Cable that can be used to extend any network beyond its physical boundaries. People love EXTNGO, they call it “Great things always come in small packages”. EXTNGO has proven to be useful in Car Diagnoses services, Hospitals, Schools, Digital Audio / Video production studios, and every single house in the united states that needs a simple and easy temporary network setup in their back yard, basement or any gaming area that needs reliable network connection. EXTNGO is a onetime investment for a life time problem. With EXTNGO, you will setup your temporary network swiftly and you will be able to retract the cable, store it nice and neatly. EXTNGO is all about being ready to deploy a network fast, and remove the cables even faster after the gig has finished.
EXTNGO comes in two color coded versions, the Orange is 50 Feet and the Green is 33 Feet. To eliminate any cable length doubts.
EXTNGO available on AMAZON.com only, you will not find it in your local market.
http://amzn.to/2wT4YHK
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
To view the multimedia release go to:
https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
